Please assess the completion status of the following clinical trial:

Trial Title: Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Successfully completed the entire treatment period in a qualifying study (TA-301 \[NCT00790751\] or TA-302 \[NCT00809471\]);~* Demonstrated compliance with the study protocol, including drug administration, diary completion, and scheduled study visits, during the qualifying trial;~* Made at least 4 attempts at intercourse during the last treatment period of the qualifying trial;~* Agree to make at least 4 attempts at intercourse each month through the course of this study;~* Agree not to use any other treatments for erectile dysfunction during participation in this study.~* Provide written informed consent;~* Willing and able to comply with scheduled study visits, treatment plan, laboratory tests, and other study procedures.~Exclusion Criteria:~* Subjects who, in the opinion of the investigator, have developed one or more comorbidities during the qualifying study that would pose a safety concern to their continuation on treatment in study TA-314;~* Subjects requiring treatment with an excluded medication.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- avanafil (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).